Cargando…
Amyloid Beta and MicroRNAs in Alzheimer’s Disease
Alzheimer’s disease (AD) is a progressive mental illness characterized by memory loss and multiple cognitive impairments. In the last several decades, significant progress has been made in understanding basic biology, molecular mechanisms, and development of biomarkers and therapeutic drugs. Multipl...
Autores principales: | Amakiri, Nnana, Kubosumi, Aaron, Tran, James, Reddy, P. Hemachandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510214/ https://www.ncbi.nlm.nih.gov/pubmed/31130840 http://dx.doi.org/10.3389/fnins.2019.00430 |
Ejemplares similares
-
Mitochondrial MicroRNAs in Aging and Neurodegenerative Diseases
por: John, Albin, et al.
Publicado: (2020) -
MicroRNA-455-3p as a Potential Biomarker for Alzheimer's Disease: An Update
por: Kumar, Subodh, et al.
Publicado: (2018) -
Amyloid Beta in Aging and Alzheimer’s Disease
por: Sehar, Ujala, et al.
Publicado: (2022) -
Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer’s Disease
por: Reddy, P. Hemachandra, et al.
Publicado: (2019) -
Synaptosome microRNAs regulate synapse functions in Alzheimer’s disease
por: Kumar, Subodh, et al.
Publicado: (2022)